A history of deep brain stimulation: Technological innovation and the role of clinical assessment tools

Social Studies of Science

Volumn 43, Issue 5, 2013, Pages 707-728

  Gardner, John ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

clinical assessment tools; deep brain stimulation; immutable mobiles; industry; innovation; medical device; technology

Indexed keywords

EID: 84884474855     PISSN: 03063127     EISSN: 14603659     Source Type: Journal    
DOI: 10.1177/0306312713483678     Document Type: Article

References (86)

1. Ackerman SJHard Science, Hard Choices: Facts, Ethics and Policies Guiding Brain Science Today. New York: Dana Press; 2006:.
2. Andy OJ.Thalamic stimulation for control of movement disorders.Applied Neurophysiology. 1983;46 (1-4): 107-111.
3. Bagby RM,Ryder A,Schuller D,Marshall MB.The Hamilton Depression Rating Scale: Has the gold standard become a lead weight?.American Journal of Psychiatry. 2004;161 (12): 2163-2177.
4. Bell E,Mathieu G,Racine E.Preparing the ethical future of deep brain stimulation.Surgical Neurology. 2009;72 (6): 577-586.
5. Benabid AL,Pollak P,Louveau A,Henry S,de Rougemont J.Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease.Applied Neurophysiology. 1987;50 (1-6): 344-346.
6. Bergman H,Wichmann T,DeLong MR.Reversal of experimental parkinsonism by lesions of the subthalamic nucleus.Science. 1990;249:1436-1438.
7. Blomstedt P,Hariz MI.Deep brain stimulation for movement disorders before DBS for movement disorders.Parkinsonism & Related Disorders. 2010;16 (7): 429-433.
8. Blume SThe Artificial Ear: Cochlear Implants and the Culture of Deafness. Piscataway, NJ: Rutgers University Press; 2010:.
9. Bodewitz H,Buurma H,De Vries GHThe Social Construction of Technological Systems: New Directions in the Sociology and History of Technology. Bijker WEHughes TPPinch T, ed. London: MIT Press; 1989:243-260.
10. Breggin PCongressional Record. Washington, DC: United States Government Printing Office; 1972:.
11. Brice J,McLellan L.Suppression of intention tremor by contingent deep-brain stimulation.Lancet. 1980;315 (8180): 1221-1222.
12. Brown N,Webster ANew Medical Technologies and Society: Reordering Life. Cambridge: Polity Press; 2004:.
13. Burke RE,Fahn S,Marsden CD,Bressman SB,Moskowitz C, et al.Validity and reliability of a rating scale for the primary torsion dystonias.Neurology. 1985;35 (1): 73-77.
14. Chiueh CC,Markey SP,Burns RS,Johannessen J,Jacobowitz DM.Neurochemical and behavioral effects of of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in rat, guinea pig and monkey.Psychopharmacology Bulletin. 1984;20 (3): 548-553.
15. Chou KL,Grube S,Patil PGDeep Brain Stimulation: A New Life for People with Parkinson's, Dystonia and Essential Tremor. New York: Demos Medical Publishing; 2012:.
16. Coffey RJ.Deep brain stimulation for chronic pain: Results of two multicentre trials and a structured review.Pain Medicine. 2001;2 (3): 183-192.
17. Coffey RJ.Deep brain stimulation devices: A brief technical history and review.Artificial Organs. 2009;33 (3): 208-220.
18. Coffey RJ,Lozano AM.Neurostimulation for chronic noncancer pain: An evaluation of the clinical evidence and recommendations for future trial designs.Journal of Neurosurgery. 2006;105 (2): 175-189.
19. Cooper I,Upton ARM.Use of chronic cerebellar stimulation for disorders of disinhibition.Lancet. 1978;311 (8064): 595-600.
20. Cooper I,Upton ARM,Amin I.Reversibility of chronic neurologic deficits: Some effects of electrical stimulation of the thalamus and internal capsule in man.Applied Neurophysiology. 1980;43 (3-5): 224-258.
21. De Laet M,Mol A.The Zimbabwe bush pump: Mechanics of a fluid technology.Social Studies of Science. 2000;30 (2): 225-263.
22. DeLong MR.Primate models of movement disorders of basal ganglia origin.Trends in Neurosciences. 1990;13 (7): 281-285.
23. Dworkin RH,Turk DC,Farrar JT,Haythornthwaite JA,Jensen MP, et al.Core outcome measures for chronic pain clinical trials: IMMPACT recommendations.Pain. 2005;113 (1-2): 9-19.
24. Fahn S,Elton RRecent Developments in Parkinson's Disease. Fahn SMarsden CDCalne DGoldstein M, ed. Florham Park, NJ: Macmillan Health Care Information; 1987:153-163.
25. Faulkner AMedical Technology into Healthcare and Society: A Sociology of Devices, Innovation and Governance. New York, NY: Palgrave Macmillan; 2009:.
26. Fins JJ,Schiff ND.Conflicts of interest in deep brain stimulation research and the ethics of transparency.Journal of Clinical Ethics. 2010;21 (2): 125-132.
27. Fins JJ, Mayberg HS, Nuttin B, Kubu CS, Galert T, et al.Misuse of the FDA's humanitarian device exemption in deep brain stimulation for obsessive-compulsive disorder.Health Affairs. 2011;30 (2): 302-311.
28. Food and Drug Administration (FDA) (1997) Premarket notification: Implantable deep brain stimulation for the treatment of tremor due to Parkinson's disease and essential tremor. In: Neurological devices panel meeting of the Medical Devices Advisory Committee, Gaithersburg, MD, 14 March. Washington, DC: Miller Reporting Company. Available at: www.fda.gov/ohrms/dockets/ac/97/transcpt/3273t1.rtf(accessed on 25 November 2011).
29. Foote SB.Loops and loopholes: Hazardous device regulation under the 1976 medical device amendments to the Food, Drug and Cosmetic Act.Ecology Law Quarterly. 1978;7:101-135.
30. French L,Story JL,Galicich J,Schultz EA.Some aspects of stimulation and recording from the basal ganglia in patients with abnormal movements.Confinia Neurologica. 1962;22:265-273.
31. Gilbert F,Ovadia D.Deep brain stimulation in the media: Over-optimistic portrayals call for a new strategy involving journalists and scientists in ethical debate.Frontiers in Integrative Neuroscience. 2011;5:1-6.
32. Gildenberg PLFifty Years of Neurosurgery. Barrow DLKondziolka DSLaws ERTraynelis VC, ed. New York, NY: Lippincott Williams & Wilkins; 2000:295-320.
33. Gildenberg PL.Evolution of neuromodulation.Stereotactic and Functional Neurosurgery. 2005;83 (2-3): 71-79.
34. Gildenberg PLNeuromodulation. Krames ESPeckham PHRezai AR, ed. Amsterdam: Elsevier and Academic Press; 2009:9-20.
35. Gillett G.The gold-plated leucotomy standard and deep brain stimulation.Journal of Bioethical Inquiry. 2011;8:35-44.
36. Goetz C, Poewe W, Rascol O, Sampaio C, Stebbins G, et al.The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations.Movement Disorders. 2003;18 (7): 738-750.
37. Goetz CG,Stebbins GT,Chmura TA,Fahn S,Klawans HL, et al.Teaching tape for the motor section of the unified Parkinson's Disease Rating Scale.Movement Disorders. 1995;10 (3): 263-266.
38. Hariz ML,Blomstedt P,Zrinzo L.Deep brain stimulation between 1947 and 1987: The untold story.Neurosurgical Focus. 2010;29 (2): E1.
39. Heath RG.Modulation of emotion with a brain pacemaker: Treatment for intractable psychiatric illness.Journal of Nervous and Mental Disease. 1977;165:300-317.
40. Heath R,Llewellyn R,Rouchell AM.The cerebellar pacemaker for intractable behavioral disorders and epilepsy: Follow up report.Biological Psychiatry. 1980;15 (2): 243-256.
41. Hester M.Special section: Technology and the body: Linking life and technology (guest editorial).Cambridge Quarterly of Healthcare Ethics. 2007;16 (3): 254-256.
42. Hosobuchi Y,Adams JE,Rutkin B.Chronic thalamic stimulation for the control of facial anesthesia dolorosa.Archives of Neurology. 1973;29 (3): 158-161.
43. Hunter DPublic Health Policy. Cambridge: Cambridge University Press; 2003:.
44. Kringelbach M,Aziz T.Deep brain stimulation: Avoiding the errors of psychosurgery.Journal of the American Medical Association. 2009;301 (16): 1705-1707.
45. Laitinen LV,Bergenheim AT,Hariz MI.Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease.Journal of Neurosurgery. 1992;76 (1): 53-61.
46. Standards and Their Stories: How Quantifying, Classifying, and Formalizing Practices Shape Everyday Life. Lampland MStar SL, ed. Ithaca, NY: Cornell University Press; 2009:.
47. Langston JW,Forno L,Rebert CS,Irwin I.Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl 1-1,2,3,6, tetrahydropyridine (MPTP) in the squirrel monkey.Brain Research. 1984;292 (2): 390-394.
48. Latour B,Woolgar SLaboratory Life: The Construction of Scientific Facts. Princeton, NJ: Princeton University Press; 1986:.
49. Latour BScience in Action. Cambridge, MA: Harvard University Press; 1987:.
50. Latour BWe Have Never Been Modern. Cambridge, MA: Harvard University Press; 1993:.
51. McGee EM,Maguire GQ.Becoming borg to become immortal: Regulating brain implant technologies.Cambridge Quarterly of Healthcare Ethics. 2007;16 (3): 291-302.
52. Mashour GA,Walker E,Martuza RL.Psychosurgery: Past, present, and future.Brain Research Reviews. 2005;48 (3): 409-419.
53. Mayberg HS,Lozano AM,Voon V,McNeely H,Seminowicz D, et al.Deep brain stimulation for treatment-resistant depression.Neuron. 2005;45 (5): 651-660.
54. Innovating for Life: 2010 Annual Report. Minneapolis, MN: Medtronic; 2010:.
55. Mol AThe Logic of Care: Health and the Problem of Patient Choice. London: Routledge; 2008:.
56. Montgomery EB,Gale JT.Mechanisms of action of deep brain stimulation (DBS).Neuroscience and Biobehavioral Reviews. 2008;32 (3): 388-407.
57. Morlacchi P,Nelson RR.How medical practice evolves: Learning to treat failing hearts with an implantable device.Research Policy. 2011;40 (4): 511-525.
58. Mullett K.State of the art in neurostimulation.PACE: Pacing and Clinical Electrophysiology. 1987;10 (1): 162-175.
59. Mundinger F.Stereotaxic interventions on the zona incerta area for treatment of extrapyramidal motor disturbances and their results.Confinia Neurologica. 1965;26 (3): 222-230.
60. Mundinger F.New stereotactic treatment of spasmodic torticollis with a brain stimulation system.Medizinische Klinik. 1977;72:1982-1986.
61. Nashold BS Jr,Slaughter DG.Effects of stimulating or destroying the deep cerebellar regions in man.Journal of Neurosurgery. 1969;31 (2): 172-186.
62. Penfield W.Epilepsy and surgical therapy.Archives of Neurology and Psychiatry. 1936;36 (3): 449-484.
63. PorrasGLiQBezardE (2012) Modeling Parkinson's disease in primates: The MPTP model. Cold Spring Harbor Perspectives in Medicine2(3). Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282499/ (accessed on 15 December 2012).
64. Porter TM.Making things quantitative.Science in Context. 1994;7 (3): 389-407.
65. Porter TMTrust in Numbers: The Pursuit of Objectivity in Science and Daily Life. Princeton, NJ: Princeton University Press; 1995:.
66. The Foucault Reader: An Introduction to Foucault's Thought. Rabinow P, ed. London: Penguin; 1991:.
67. Racine E,Waldman S,Palmour N,Risse D,Illes J.'Currents of hope': Neurostimulation techniques in U.S and U.K. print media.Cambridge Quarterly of Healthcare Ethics. 2007;16 (3): 312-316.
68. Ritzer GThe McDonaldization of Society: An Investigation into the Changing Character of Contemporary Social Life. Thousand Oaks, CA: Pine Forge Press; 1996:.
69. Rosenow J,Das K,Rovit RL,Couldwell WT.Irving S. Cooper and his role in intracranial stimulation for movement disorders and epilepsy.Stereotactic and Functional Neurosurgery. 2002;78 (2): 95-112.
70. Rossi UElectrical Stimulation and the Relief of Pain. Simpson BA, ed. Amsterdam: Elsevier; 2003:5-16.
71. Schermer M.Ethical issues in deep brain stimulation.Frontiers in Integrative Neuroscience. 2011;5:17.
72. Schlaepfer TE,Fins JJ.Deep brain stimulation and the neuroethics of responsible publishing: When one is not enough.Journal of the American Medical Association. 2010;303 (8): 775-776.
73. Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, et al.Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression.Neuropsychopharmacology. 2008;33(2):368-377.
74. Sem-Jacobsen CW.Depth-electrographic observations related to Parkinson's disease: Recording and electrical stimulation in the area around the third ventricle.Journal of Neurosurgery. 1966;24 (1): 388-402.
75. Shatin D,Mullet K,Hults G.Totally implantable spinal cord stimulation for chronic pain: Design and efficacy.PACE: Pacing and Clinical Electrophysiology. 1986;9 (4): 577-583.
76. Shealy N,Mortimier JT,Reswick JB.Electrical inhibition of pain by stimulation of the dorsal columns: Preliminary clinical report.Anesthesia and Analgesia. 1967;46 (4): 489-491.
77. Siegfried J,Shulman J.Deep brain stimulation.PACE: Pacing and Clinical Electrophysiology. 1987;10 (1): 271-272.
78. Spiegel EA,Wycis HT,Marks M,Lee AJ.Stereotaxic apparatus for operations on the human brain.Science. 1947;106:349-350.
79. StuartM (2012) Deep brain provides stimulating market. Medtech Insight14(4). Available at: http://www.elsevierbi.com/publications/medtech-insight/14/4/deep-brain-provides-stimulatingmarket (accessed on 15 December 2012).
80. Taghva A,Corrigan JD,Rezai AR.Obesity and brain addiction circuitry: Implications for deep brain stimulation.Neurosurgery. 2012;71 (2): 224-238.
81. Talan JDeep Brain Stimulation: A New Treatment Shows Promise in the Most Difficult Cases. New York: Dana Press; 2009:.
82. Timmermans S,Berg MThe Gold Standard: The Challenge of Evidence-Based Medicine and Standardization in Health Care. Philadelphia, PA: Temple University Press; 2003:.
83. Upton A.Biostimulation.PACE: Pacing and Clinical Electrophysiology. 1986;9:3-7.
84. Upton A,Lazorthes Y.Editorial.PACE: Pacing and Clinical Electrophysiology. 1987;10:161.
85. Valenstein EThe History of Neurosurgery. Greenblatt SH, ed. Park Ridge, IL: AANS; 1997:499-516.
86. Wehrens R,Bal R.Health programs struggling with complexity: A case study of the Dutch 'PreCare' project.Social Science & Medicine. 2012;75 (2): 274-282.